Cardiac taurine and principal amino acids in right and left ventricles of patients with either aortic valve stenosis or coronary artery disease: the importance of diabetes and gender

SpringerPlus

Volumn 3, Issue 1, 2014, Pages

  Lewis, Martin ^a   Littlejohns, Ben ^a   Lin, Hua ^a   Angelini, Gianni D ^a   Suleiman, M Saadeh ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Alanine; Aortic valve stenosis; Coronary artery disease; Glutamate; Glutamine; Hypertrophy; Left and right ventricle; Taurine

Indexed keywords

EID: 84933519191     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-3-523     Document Type: Article

References (60)

1. Allo SN, Bagby L, Schaffer SW: Taurine depletion, a novel mechanism for cardioprotection from regional ischemia.Am J Physiol 1997, 273:H1956-H1961.
2. Ascione R, Gomes WJ, Angelini GD, Bryan AJ, Suleiman MS: Warm blood cardioplegia reduces the fall in the intracellular concentration of taurine in the ischaemic/reperfused heart of patients undergoing aortic valve surgery.Amino Acids 1998, 15:339–350. 10.1007/BF01320898
3. Blankstein R, Ward RP, Arnsdorf M, Jones B, Lou YB, Pine M: Female gender is an independent predictor of operative mortality after coronary artery bypass graft surgery: contemporary analysis of 31 Midwestern hospitals.Circulation 2005, 112:I323-I327. doi:10.1161/CIRCULATIONAHA.104.525139
4. Caputo M, Bryan AJ, Calafiore AM, Suleiman MS, Angelini GD: Intermittent antegrade hyperkalaemic warm blood cardioplegia supplemented with magnesium prevents myocardial substrate derangement in patients undergoing coronary artery bypass surgery.Eur J Cardiothorac Surg 1998, 14:596–601. 10.1016/S1010-7940(98)00247-4
5. Caputo M, Dihmis WC, Bryan AJ, Suleiman MS, Angelini GD: Warm blood hyperkalaemic reperfusion (‘hot shot’) prevents myocardial substrate derangement in patients undergoing coronary artery bypass surgery.Eur J Cardiothorac Surg 1998, 13:559–564. 10.1016/S1010-7940(98)00056-6
6. Chapman RA, Suleiman MS, Earm YE: Taurine and the heart.Cardiovasc Res 1993, 27:358–363. 10.1093/cvr/27.3.358
7. Cooper MW, Lombardini JB: Elevated blood taurine levels after myocardial infarction of cardiovascular surgery: is there any significance?Adv Exp Med Biol 1981, 139:191–205.
8. Das J, Vasan V, Sil PC: Taurine exerts hypoglycemic effect in alloxan-induced diabetic rats, improves insulin-mediated glucose transport signaling pathway in heart and ameliorates cardiac oxidative stress and apoptosis.Toxicol Appl Pharmacol 2012, 258:296–308. doi:10.1016/j.taap.2011.11.009 10.1016/j.taap.2011.11.009
9. Di Carli M, Czernin J, Hoh CK, Gerbaudo VH, Brunken RC, Huang SC, Phelps ME, Schelbert HR: Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease.Circulation 1995, 91:1944–1951. 10.1161/01.CIR.91.7.1944
10. Franconi F, Bennardini F, Mattana A, Miceli M, Ciuti M, Mian M, Gironi A, Anichini R, Seghieri G: Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation.Am J Clin Nutr 1995, 61:1115–1119.
11. Franconi F, Di Leo MA, Bennardini F, Ghirlanda G: Is taurine beneficial in reducing risk factors for diabetes mellitus?Neurochem Res 2004, 29:143–150.
12. Garcia-Dorado D, Oliveras J: Myocardial oedema: a preventable cause of reperfusion injury?Cardiovasc Res 1993, 27:1555–1563. 10.1093/cvr/27.9.1555
13. Gossai D, Lau-Cam CA: The effects of taurine, taurine homologs and hypotaurine on cell and membrane antioxidative system alterations caused by type 2 diabetes in rat erythrocytes.Adv Exp Med Biol 2009, 643:359–368. doi:10.1007/978–0-387–75681–3_37 10.1007/978-0-387-75681-3_37
14. Gould KL: Assessing progression or regression of CAD: the role of perfusion imaging.J Nucl Cardiol 2005, 12:625–638. doi:10.1016/j.nuclcard.2005.09.004 10.1016/j.nuclcard.2005.09.004
15. Gould KL, Lipscomb K, Calvert C: Compensatory changes of the distal coronary vascular bed during progressive coronary constriction.Circulation 1975, 51:1085–1094. 10.1161/01.CIR.51.6.1085
16. Gould KL, Nakagawa Y, Nakagawa K, Sdringola S, Hess MJ, Haynie M, Parker N, Mullani N, Kirkeeide R: Frequency and clinical implications of fluid dynamically significant diffuse coronary artery disease manifest as graded, longitudinal, base-to-apex myocardial perfusion abnormalities by noninvasive positron emission tomography.Circulation 2000, 101:1931–1939. 10.1161/01.CIR.101.16.1931
17. Hadj A, Pepe S, Marasco S, Rosenfeldt F: The principles of metabolic therapy for heart disease.Heart Lung Circ 2003,12(Suppl 2):S55-S62.
18. Hansen SH: The role of taurine in diabetes and the development of diabetic complications.Diabetes Metab Res Rev 2001, 17:330–346. 10.1002/dmrr.229
19. Higgins J, Jamieson WR, Benhameid O, Ye J, Cheung A, Skarsgard P, Germann E, Chan F, Lichtenstein SV: Influence of patient gender on mortality after aortic valve replacement for aortic stenosis.J Thorac Cardiovasc Surg 2011, 142:595–601. 601 e591–592 doi:10.1016/j.jtcvs.2010.05.056 10.1016/j.jtcvs.2010.05.056
20. Huxtable RJ: Taurine and the heart.Cardiovasc Res 1993, 27:1136–1137.
21. Ito T, Kimura Y, Uozumi Y, Takai M, Muraoka S, Matsuda T, Ueki K, Yoshiyama M, Ikawa M, Okabe M, Schaffer SW, Fujio Y, Azuma J: Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy.J Mol Cell Cardiol 2008, 44:927–937. 10.1016/j.yjmcc.2008.03.001
22. Kazmi SM, Baquer NZ: Influence of alloxan diabetes and insulin treatment on the activity of alanine aminotransferase in rat brain regions, liver and heart.Enzyme 1985, 34:57–63.
23. Kazmi SM, Mayanil CS, Baquer NZ: Malate-aspartate shuttle enzymes in rat brain regions, liver and heart during alloxan diabetes and insulin replacement.Enzyme 1985, 34:98–106.
24. King N, McGivan JD, Griffiths EJ, Halestrap AP, Suleiman MS: Glutamate loading protects freshly isolated and perfused adult cardiomyocytes against intracellular ROS generation.J Mol Cell Cardiol 2003, 35:975–984. 10.1016/S0022-2828(03)00182-2
25. Li C, Cao L, Zeng Q, Liu X, Zhang Y, Dai T, Hu D, Huang K, Wang Y, Wang X, Li D, Chen Z, Zhang J, Li Y, Sharma R: Taurine may prevent diabetic rats from developing cardiomyopathy also by downregulating angiotensin II type2 receptor expression.Cardiovasc Drugs Ther 2005, 19:105–112. doi:10.1007/s10557–005–0443-x 10.1007/s10557-005-0443-x
26. Lombardini JB, Bricker DL: Effects of cardiovascular surgery on blood concentrations of taurine and amino acids.Proc Soc Exp Biol Med 1981, 167:498–505. 10.3181/00379727-167-41204
27. Lombardini JB, Cooper MW: Elevated blood taurine levels in acute and evolving myocardial infarction.J Lab Clin Med 1981, 98:849–859.
28. Lotto AA, Ascione R, Caputo M, Bryan AJ, Angelini GD, Suleiman MS: Myocardial protection with intermittent cold blood during aortic valve operation: antegrade versus retrograde delivery.Ann Thorac Surg 2003, 76:1227–1233. discussion 1233 10.1016/S0003-4975(03)00840-3
29. Newman WH, Frangakis CJ, Grosso DS, Bressler R: A relation between myocardial taurine contest and pulmonary wedge pressure in dogs with heart failure.Physiol Chem Phys 1977, 9:259–263.
30. Parildar H, Dogru-Abbasoglu S, Mehmetcik G, Ozdemirler G, Kocak-Toker N, Uysal M: Lipid peroxidation potential and antioxidants in the heart tissue of beta-alanine- or taurine-treated old rats.J Nutr Sci Vitaminol 2008, 54:61–65. 10.3177/jnsv.54.61
31. Petrov G, Regitz-Zagrosek V, Lehmkuhl E, Krabatsch T, Dunkel A, Dandel M, Dworatzek E, Mahmoodzadeh S, Schubert C, Becher E, Hampl H, Hetzer R: Regression of myocardial hypertrophy after aortic valve replacement: faster in women?Circulation 2010, 122:S23-S28. doi:10.1161/CIRCULATIONAHA.109.927764 10.1161/CIRCULATIONAHA.109.927764
32. Rennie MJ, Tadros L, Khogali S, Ahmed A, Taylor PM: Glutamine transport and its metabolic effects.J Nutr 1994, 124:1503S-1508S.
33. Rennie MJ, Bowtell JL, Bruce M, Khogali SE: Interaction between glutamine availability and metabolism of glycogen, tricarboxylic acid cycle intermediates and glutathione.J Nutr 2001, 131:2488S-2490S. discussion 2496S–2487S
34. Robertson JM, Vinten-Johansen J, Buckberg GD, Rosenkranz ER, Maloney JV Jr: Safety of prolonged aortic clamping with blood cardioplegia. I. Glutamate enrichment in normal hearts.J Thorac Cardiovasc Surg 1984, 88:395–401.
35. Rosenkranz ER, Okamoto F, Buckberg GD, Vinten-Johansen J, Robertson JM, Bugyi H: Safety of prolonged aortic clamping with blood cardioplegia. II. Glutamate enrichment in energy-depleted hearts.J Thorac Cardiovasc Surg 1984, 88:402–410.
36. Rosenkranz ER, Okamoto F, Buckberg GD, Robertson JM, Vinten-Johansen J, Bugyi HI: Safety of prolonged aortic clamping with blood cardioplegia. III. Aspartate enrichment of glutamate-blood cardioplegia in energy-depleted hearts after ischemic and reperfusion injury.J Thorac Cardiovasc Surg 1986, 91:428–435.
37. Ruiz-Meana M, Garcia-Dorado D, Gonzalez MA, Barrabes JA, Soler-Soler J: Effect of osmotic stress on sarcolemmal integrity of isolated cardiomyocytes following transient metabolic inhibition.Cardiovasc Res 1995, 30:64–69. 10.1016/S0008-6363(95)00008-9
38. Schaffer SW, Ballard-Croft C, Azuma J, Takahashi K, Kakhniashvili DG, Jenkins TE: Shape and size changes induced by taurine depletion in neonatal cardiomyocytes.Amino Acids 1998, 15:135–142. 10.1007/BF01345286
39. Schaffer SW, Solodushko V, Kakhniashvili D: Beneficial effect of taurine depletion on osmotic sodium and calcium loading during chemical hypoxia.Am J Physiol Cell Physiol 2002, 282:C1113-C1120. 10.1152/ajpcell.00485.2001
40. Schaffer SW, Jong CJ, Ramila KC, Azuma J: Physiological roles of taurine in heart and muscle.J Biomed Sci 2010,17(Suppl 1):S2. doi:10.1186/1423–0127–17-S1-S2 10.1186/1423-0127-17-S1-S2
41. Schaffer SW, Jong CJ, Ito T, Azuma J: Effect of taurine on ischemia-reperfusion injury.Amino Acids 2014, 46:21–30. doi:10.1007/s00726–012–1378–8 10.1007/s00726-012-1378-8
42. Scharff R, Wool IG: Effect of diabetes on the concentration of amino acids in plasma and heart muscle of rats.Biochem J 1966, 99:173–178.
43. Schindhelm RK, Dekker JM, Nijpels G, Bouter LM, Stehouwer CD, Heine RJ, Diamant M: Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study.Atherosclerosis 2007, 191:391–396. doi:10.1016/j.atherosclerosis.2006.04.006 10.1016/j.atherosclerosis.2006.04.006
44. Suleiman MS, Chapman RA: Calcium paradox in newborn and adult guinea-pig hearts: changes in intracellular taurine and the effects of extracellular magnesium.Exp Physiol 1993, 78:503–516.
45. Suleiman MS, Chapman RA: Changes in the principal free intracellular amino acids in the Langendorff perfused guinea pig heart during arrest with calcium-free or high potassium media.Cardiovasc Res 1993, 27:1810–1814. 10.1093/cvr/27.10.1810
46. Suleiman MS, Rodrigo GC, Chapman RA: Interdependence of intracellular taurine and sodium in guinea pig heart.Cardiovasc Res 1992, 26:897–905. 10.1093/cvr/26.9.897
47. Suleiman MS, Fernando HC, Dihmis WC, Hutter JA, Chapman RA: A loss of taurine and other amino acids from ventricles of patients undergoing bypass surgery.Br Heart J 1993, 69:241–245. 10.1136/hrt.69.3.241
48. Suleiman MS, Moffatt AC, Dihmis WC, Caputo M, Hutter JA, Angelini GD, Bryan AJ: Effect of ischaemia and reperfusion on the intracellular concentration of taurine and glutamine in the hearts of patients undergoing coronary artery surgery.Biochim Biophys Acta 1997, 1324:223–231. 10.1016/S0005-2736(96)00225-8
49. Suleiman MS, Caputo M, Ascione R, Bryan AJ, Lucchetti V, Gomes WJ, Angelini GD: Metabolic differences between hearts of patients with aortic valve disease and hearts of patients with ischaemic disease.J Mol Cell Cardiol 1998, 30:2519–2523. doi:10.1006/jmcc.1998.0814 10.1006/jmcc.1998.0814
50. Suleiman MS, Halestrap AP, Griffiths EJ: Mitochondria: a target for myocardial protection.Pharmacol Ther 2001, 89:29–46. 10.1016/S0163-7258(00)00102-9
51. Suleiman MS, Zacharowski K, Angelini GD: Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics.Br J Pharmacol 2008, 153:21–33. 10.1038/sj.bjp.0707526
52. Suleiman MS, Hancock M, Shukla R, Rajakaruna C, Angelini GD: Cardioplegic strategies to protect the hypertrophic heart during cardiac surgery.Perfusion 2011,26(Suppl 1):48–56.
53. Takahashi K, Ohyabu Y, Takahashi K, Solodushko V, Takatani T, Itoh T, Schaffer SW, Azuma J: Taurine renders the cell resistant to ischemia-induced injury in cultured neonatal rat cardiomyocytes.J Cardiovasc Pharmacol 2003, 41:726–733. 10.1097/00005344-200305000-00009
54. Takatani T, Takahashi K, Uozumi Y, Matsuda T, Ito T, Schaffer SW, Fujio Y, Azuma J: Taurine prevents the ischemia-induced apoptosis in cultured neonatal rat cardiomyocytes through Akt/caspase-9 pathway.Biochem Biophys Res Commun 2004, 316:484–489. 10.1016/j.bbrc.2004.02.066
55. Takatani T, Takahashi K, Uozumi Y, Shikata E, Yamamoto Y, Ito T, Matsuda T, Schaffer SW, Fujio Y, Azuma J: Taurine inhibits apoptosis by preventing formation of the Apaf-1/caspase-9 apoptosome.Am J Physiol Cell Physiol 2004, 287:C949-C953. doi:10.1152/ajpcell.00042.2004 10.1152/ajpcell.00042.2004
56. Tappia PS, Thliveris J, Xu YJ, Aroutiounova N, Dhalla NS: Effects of amino acid supplementation on myocardial cell damage and cardiac function in diabetes.Exp Clin Cardiol 2011, 16:e17-e22.
57. Tappia PS, Xu YJ, Rodriguez-Leyva D, Aroutiounova N, Dhalla NS: Cardioprotective effects of cysteine alone or in combination with taurine in diabetes.Physiol Res 2013, 62:171–178.
58. Tritto FP, Inserte J, Garcia-Dorado D, Ruiz-Meana M, Soler-Soler J: Sodium/hydrogen exchanger inhibition reduces myocardial reperfusion edema after normothermic cardioplegia.J Thorac Cardiovasc Surg 1998, 115:709–715. 10.1016/S0022-5223(98)70337-X
59. Venturini A, Ascione R, Lin H, Polesel E, Angelini GD, Suleiman MS: The importance of myocardial amino acids during ischemia and reperfusion in dilated left ventricle of patients with degenerative mitral valve disease.Mol Cell Biochem 2009, 330:63–70. doi:10.1007/s11010–009–0101-x 10.1007/s11010-009-0101-x
60. Williams H, King N, Griffiths EJ, Suleiman MS: Glutamate-loading stimulates metabolic flux and improves cell recovery following chemical hypoxia in isolated cardiomyocytes.J Mol Cell Cardiol 2001, 33:2109–2119. 10.1006/jmcc.2000.1474